Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Association of longitudinal changes of genomic alteration of circulating tumor DNA with treatment response in pancreatic cancer.
Authors
Jin Ho Choi
Samsung Medical Center, Seoul, South Korea
Jin Ho Choi , Sang Hyub Lee , Woo Hyun Paik , Junyeol Kim , Tae Seung Lee , Myeong Hwan Lee , In Rae Cho , Ji Kon Ryu , Yong-Tae Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 701)
DOI
10.1200/JCO.2024.42.3_suppl.701
Abstract #
701
Poster Bd #
N10
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Development and application of an ultra-sensitive ctDNA mutation profiling assay in monitoring therapy response and drug resistance.
First Author: Tom Zhang
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Concordance of genomic alterations in anal cancer by next-generation sequencing in tissue and circulating tumor DNA.
First Author: Michael Brian LaPelusa
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Patient-specific tumor-informed circulating tumor DNA (ctDNA) assay to predict cancer recurrence in patients with resected pancreatic cancer.
First Author: Xiuchao Wang
Poster
2022 ASCO Quality Care Symposium
Real-world uptake and concordance of actionable genetic mutations between tissue NGS and liquid biopsy in oncology patients in a safety-net hospital: A single center analysis.
First Author: Steven Badami